Tyra Biosciences, Inc. Other Accrued Liabilities, Current
Financial Statements › Balance Sheet › Liabilities › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Other Accrued Liabilities, Current $21.78M.
- 2026-03-31: Other Accrued Liabilities, Current $15.13M.
- 2025-12-31: Other Accrued Liabilities, Current $16.44M.
- 2025-09-30: Other Accrued Liabilities, Current $13.43M.
| Period end | Other Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $21.78M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $15.13M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $16.44M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $13.43M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $11.08M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $11.32M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $13.59M 10-K · filed 2026-03-02 |
| 2024-09-30 | $10.81M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $8.42M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $5.47M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $10.39M 10-K · filed 2025-03-27 |
| 2023-09-30 | $7.69M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.82M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.26M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $4.42M 10-K · filed 2024-03-19 |
| 2022-09-30 | $2.62M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.99M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.43M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.81M 10-K · filed 2023-03-22 |
| 2021-09-30 | $2.56M 10-Q · filed 2021-11-03 |
| 2020-12-31 | $1.05M 10-K · filed 2022-03-03 |